Regeneron COVID-19 antibody cocktail helps prevent symptomatic disease in study

By Admin
April 12, 2021 in Latest US News

Recommended Posts

Admin

Posted April 12, 2021

- Share

Posted April 12, 2021

A monoclonal antibody cocktail developed by Regeneron and Roche dropped the risk of symptomatic COVID-19 by up to 76% after three days for recently infected individuals not yet experiencing symptoms, according to a press release posted Monday.

View the full article

Link to comment

Share on other sites

Archived

This topic is now archived and is closed to further replies.

Go to topic listing

Recently Browsing 0 members
- No registered users viewing this page.

Sign In

Regeneron COVID-19 antibody cocktail helps prevent symptomatic disease in study

Recommended Posts

Admin

Link to comment

Share on other sites

Archived

Recently Browsing 0 members

More

Support

Important Information